The goals of the Smilow Cancer Genetics and Prevention Program are to provide a multidisciplinary, comprehensive approach to the care of patients at increased risk of cancer, to make new research advances in the field, and to improve awareness about cancer risk and prevention through education and community outreach in New Haven and the state of Connecticut.
Our aims are:
Clinical: Provide patient-centered care and foster collaboration amongst healthcare providers.
Research: Advance the field of cancer genetics, risk prediction and prevention, and related treatment options
Education: Provide clinical/didactic experiences for genetic counseling students, medical students, residents, fellows, and other providers
Community Outreach: Promote awareness of hereditary cancer risk and provide broad-based education about cancer prevention options
Our Program is a component of Yale Cancer Center, a comprehensive cancer center designated by the National Cancer Institute.
For more information, or to schedule an appointment with Smilow Cancer Genetics and Prevention, please call
Genetics CME | October 28, 2021Implementing Screening and Prevention Strategies for Individuals Identified to be at Increased Risk for CancerPresentations by:Melanie Lynch, MD | Elena Ratner, MD | Xavier Llor, MD, PhD | James Farrell, MBChB
Smilow Cancer Hospital’s Dr. Xavier Llor discusses the evolution of genetic testing over the last 10-15 years and current testing that is available, as part of the new web module from HealthExperiencesUSA called ‘Cancer Risk that Runs in Families.’
Dr. Erin Hofstatter, Amanda Ganzak, Licensed Genetic Counselor, Camille Varin-Tremblay, Licensed Genetic Counselor, and Elizabeth Del Buono, Licensed Genetic Counselor, share information about genetic counseling and testing.
Breast Reconstruction Options | Dr. Tomer AvrahamPancreatic Cancer | Dr. James FarrellRisks, Surveillance: Screening for Men w/ HBC Syndromes, melanoma, prostate, and others | Amy KillieFacilitator | Claire Healy